Medtronic, Inc. (MDT) PT Lowered to $122 at RBC Capital

Go back to Medtronic, Inc. (MDT) PT Lowered to $122 at RBC Capital

Medtronic, Inc. (MDT) PT Lowered to $111 at Truist Securities

May 27, 2022 8:09 AM EDT

Truist Securities analyst Richard Newitter lowered the price target on Medtronic, Inc. (NYSE: MDT) to $111.00 (from $121.00) while maintaining a Hold rating following earnings.

The analyst commented, "We stay at HOLD following MDT's disappointing F4Q & below CNS F1Q/FY23 guide. We appreciate MDT's... More